Detalhe da pesquisa
1.
Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker.
Ann Rheum Dis
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373842
2.
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.
Nat Commun
; 15(1): 910, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291039